SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-001364
Filing Date
2015-08-04
Accepted
2015-08-04 16:01:52
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20150630x10q.htm 10-Q 971569
2 EX-31.1 mrns-20150630ex311e7918e.htm EX-31.1 15792
3 EX-31.2 mrns-20150630ex31245b483.htm EX-31.2 15966
4 EX-32.1 mrns-20150630ex32127f0c7.htm EX-32.1 9881
  Complete submission text file 0001558370-15-001364.txt   2805594

Data Files

Seq Description Document Type Size
5 EX-101.INS mrns-20150630.xml EX-101.INS 446614
6 EX-101.SCH mrns-20150630.xsd EX-101.SCH 17334
7 EX-101.CAL mrns-20150630_cal.xml EX-101.CAL 29597
8 EX-101.DEF mrns-20150630_def.xml EX-101.DEF 44115
9 EX-101.LAB mrns-20150630_lab.xml EX-101.LAB 193912
10 EX-101.PRE mrns-20150630_pre.xml EX-101.PRE 125577
Mailing Address THREE RADNOR CORPORATE CENTER 100 MATSONFORD RD, SUITE 304 RADNOR PA 19087
Business Address THREE RADNOR CORPORATE CENTER 100 MATSONFORD RD, SUITE 304 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 151025434
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences